Affiliation:
1. School of Science, Monash University Malaysia Campus, Jalan Lagoon Selatan, Bandar Sunway, 47500, Selangor, Malaysia
Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder that has affected millions of people
worldwide. However, currently, there is no treatment to cure the disease. The AD drugs available in
the market only manage the disease symptomatically and the effects are usually short-term. Thus, there
is a need to look at alternatives AD therapies. This literature review aims to shed some light on the
potential of repurposing antihypertensives to treat AD. Mid-life hypertension has not only been recognised
as a risk factor for AD, but its relation with AD has also been well established. Hence, antihypertensives
were postulated to be beneficial in managing AD. Four classes of antihypertensives, as well as
their potential limitations and prospects in being utilised as AD therapeutics, were discussed in this
review.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献